Psychedelics may soon be available — sort of — to treat vets with PTSD
In 2017, the U.S. Food and Drug Administration designated MDMA as a “breakthrough therapy” for treatment of post-traumatic stress disorder.
Stay updated with breaking news from Breakthrough Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In 2017, the U.S. Food and Drug Administration designated MDMA as a “breakthrough therapy” for treatment of post-traumatic stress disorder.
Plan to Submit Application for Accelerated Approval for Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in H1 2024 Expects to Begin Enrollment in Phase 3 Confirmatory...
RADNOR, Pa., Nov. 7, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. , a late-stage biopharmaceutical company, today announced that it will release its third quarter 2023 financial results after the...
Potential world-first patented biomarker for long COVID Evaluating diagnostic companion with Bucillamine for long COVID TORONTO, Nov. 06, 2023 -- Revive Therapeutics Ltd. , a specialty life...
Planned Subgroup Analysis of RAMP 201 Data Showed Combination Demonstrated Robust Efficacy in Recurrent LGSOC Regardless of Number and Class of Prior Therapies Including After Poor Response to Prior TherapyLate-Breaking Abstract Featured as an Oral Presentation during a Plenary Session at the Annual Global Meeting o...